Long-term stability of effects of subthalamic stimulation in Parkinson's disease: Indian Experience

Movement Disorders

Volumn 25, Issue 14, 2010, Pages 2438-2444

  Kishore, Asha ^a   Rao, Ravimohan ^a   Krishnan, Syam ^a   Panikar, Dilip ^a   Sarma, Gangadhara ^a   Sivasanakaran, Mathuranath Pavagada ^a   Sarma, Sankara ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Asia; Deep brain stimulation; Motor fluctuations; Parkinson's disease; Subthalamic nucleus

Indexed keywords

LEVODOPA;

ADULT; AGED; ANXIETY; ARTICLE; ATTENTION; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; COGNITION; DISEASE COURSE; DYSKINESIA; ELECTROSTIMULATION; FEMALE; FOLLOW UP; HUMAN; MALE; MOOD; MOTOR DYSFUNCTION; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SCORING SYSTEM;

ADULT; ANTIPARKINSON AGENTS; ATTENTION; COGNITION DISORDERS; DEEP BRAIN STIMULATION; DYSKINESIAS; EXECUTIVE FUNCTION; FEMALE; HUMANS; INDIA; LEVODOPA; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SINGLE-BLIND METHOD; SUBTHALAMIC NUCLEUS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77958570470     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23269     Document Type: Article

References (32)

1. Deuschl G, Schade-Brittinger CS, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006; 355: 896-908.
2. Weaver FM, Follett K, Stern M, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 2009; 301: 63-73.
3. Kleiner-Fisman G, Herzog J, Fisman DN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006; 21 ( suppl 14): S290-S304.
4. Krack P, Batir A, Van Blercom N, et al. Five-year follow up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003; 349: 1925-1934.
5. Rodriguez-Oroz MC, Zamarbide I, Guridi J, Palmero MR, Obeso JA. Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease 4 years after surgery: double blind and open label evaluation. J Neurol Neurosurg Psychiatry 2004; 75: 1382-1385.
6. Rodriguez-Oroz MC, Obeso JA, Lang AE, et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain 2005; 128: 2240-2249.
7. Ostergaard K, Sundae NA. Evolution of Parkinson's disease during 4 years of bilateral deep brain stimulation of the subthalamic nucleus. Mov Disord 2005; 21: 624-631.
8. Piboolnurak P, Lang AE, Lozano AM, et al. Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease. Mov Disord 2007; 22: 990-997.
9. Schüpbach WMM, Chastan N, Welter ML, et al. Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J Neurol Neurosurg Psychiatry 2005; 76: 1640-1644.
10. Simonin C, Tir M, Devos D, et al. Reduced levodopa-induced complications after 5 years of subthalamic stimulation in Parkinson's disease: a second honey moon. J Neurol 2009; 256: 1736-1741.
11. Fahn S, Elton RL, and members of the UPDRS development committee. Unified Parkinson's rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, editors. Recent developments in Parkinson's disease. Florham Park (NJ): MacMillan; 1987. p 153-164.
12. Langston JW, Widner H, Goetz C, et al. Core assessment program for intracerebral transplantation (CAPIT). Mov Disord 1992; 7: 2-13.
13. Beck AT, Ward CH, Mendelson M, Mock J, Rraugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571.
14. Mathuranath PS, Nestor PJ, Berrios GE, Rakowicz W, Hodges JR. A brief cognitive test battery to differentiate Alzeimer's disease and frontotemporal dementia. Neurology 2000; 55: 1613-1620.
15. Mathuranath PS, Cherian JP, Mathew R, George A, Alexander A, Sarma S. Mini mental state examination and the Addenbrooke's cognitive examination: effect of education and norms for a multicultural population. Neurol India 2007; 55: 106-110.
16. de Boer AGEM, Wijker W, Speelman JD, Dehaes JCJM. Quality of life in patients with Parkinson's disease: development of a questionnaire. J Neurol Neurosurg Psychiatry 1996; 61: 70-74.
17. Marinus J, Ramaker C, van Hilten JJ, Stiggelbout AM. Health related quality of life in Parkinson's disease: a systematic review of disease specific instrument. J Neurol Neurosurg Psychiatry 2002; 72: 241-248.
18. Contarino MF, Daniele A, Sibilia AH, et al. Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2007; 78: 248-252.
19. Funkiewiez A, Ardouin C, Caputo E, et al. Long-term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood and behavior in Parkinson's disease. J Neurol Neurosug Psychiatry 2004; 75: 834-839.
20. Pilion B, Ardouin C, Damier P, et al. Neuropsychological changes between "off" and "on" STN or GPI stimulation in Parkinson's disease. Neurology 2000; 55: 411-418.
21. Witt K, Daniels C, Reiff J, et al. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomized, multicentre study. Lancet Neurol 2008; 7: 605-614.
22. Ardouin C, Pillon B, Peiffer E, et al. Bilateral subthalamic or pallidal stimulation for Parkinson's disease affects neither memory nor executive functions: a consecutive series of 62 patients. Ann Neurol 1999; 46: 217-223.
23. Saint-Cyr J, Trepanier LL, Kumar R, Lozano AM, Lang AE. Neuropsychological consequences of chronic bilateral stimulation of the subthalamic nucleus in Parkinson's disease. Brain 2000; 123: 2091-2108.
24. Kalbe E, Voges J, Weber T, et al. Frontal FDG-PET activity correlated with cognitive outcome after STN-DBS in Parkinson disease. Neurology 2009; 72: 42-49.
25. Smeding HM, Speelman JD, Hulzenga HM, Schuurman PR, Schmand B. Predictors of cognitive and psychosocial outcome after STN DBS in Parkinson's disease. J Neurol Neurosurg Psychiatry (in press).
26. Zangaglia R, Pacchetti C, Pasotti C, et al. Deep brain stimulation and cognitive functions in Parkinson's disease: a three-year controlled study. Mov Disord 2009; 24: 1621-1628.
27. Voon V, Kubu C, Krack P, Houeto JL, Troster AI. Deep brain stimulation: neuropsychological and neuropsychiatric issues. Mov Disord 2006; 21: S305-S326.
28. Berney A, Vingerhoets FJ, Perrin A, et al. Effect on mood of subthalamic DBS for Parkinson's disease. A consecutive series of 24 patients. Neurology 2002; 59: 1427-1429.
29. Mushmovic D, Post B, Speelman JD, Schmand B, de Haan RJ. Determinants of disability and quality of life in mild to moderate Parkinson disease. Neurology 2008; 70: 2241-2247.
30. Ferrara JM, Diamond A, Hunter C, Davidson A, Almaguer M, Jankovic J. Impact of STN-DBS on life and health satisfaction in patients with Parkinson's disease. J Neurol Neurosur Psychiatry (in press).
31. Volkmann J, Albanese A, Kulisevsky J, et al. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson's disease. Mov Disord 2009; 24: 1154-1161.
32. Drapier S, Raoul S, Drapier D, et al. Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson's disease. J Neurol 2005; 252: 583-588.